{
  "hash": "dd8eb3b96263e8102cb30b5b971d4ae0",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Example1:\"\noutput: \n  html_document\n---\n\n\n## Robotic vs LPS+LESS\n\n### 1 Data Collection (from Ragic database)\n\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n`````{=html}\n<div style=\"border: 1px solid #ddd; padding: 0px; overflow-y: scroll; height:400px; overflow-x: scroll; width:100%; \"><table class=\"table table-striped table-hover table-condensed lightable-paper\" style='color: black; margin-left: auto; margin-right: auto; color: black; font-family: \"Arial Narrow\", arial, helvetica, sans-serif; margin-left: auto; margin-right: auto;'>\n <thead>\n  <tr>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\">   </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 編號 </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Group </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> ECOG </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 性別 </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> BMI </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 身高..公分. </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 體重..公斤. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Comorbidity.多選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 術前主述.複選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Cell.Type </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 左右側 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 腫瘤位置.多選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 多發性 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 腫瘤大小 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 病理分期 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 完整檢體腫瘤惡性度 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 危險因子..複選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 合併膀胱腫瘤 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 合併CIS </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Lymphovascular.invasion </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> surgical.margin </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 術前水腎 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Tumor.Necrosis </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 有無針對UTUC化療 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 針對UTUC化療型態 </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> NxUx.date </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> NxUx.Access.method..複選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Other.NxUx.access.method </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Bladder.cuff.resection </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> other.bladder.cuff.method </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Lymphadenectomy.位置.複選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> simultaneously.ipsilateral.adrenalectomy </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Specimen.retrieval..註.若直接從傷口取出則選1.or.2.若有使用bag選擇輸入4.5. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Post.operation.intravesical.C.T.instillation </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Clavien.Dindo.classification.複選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> complication.list..請填寫手術併發症中英文均可. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 淋巴轉移及位置..複選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Date.of.LN.mets </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 遠端轉移.複選. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Date.of.distant.mets </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Disease.free.註.不含膀胱內復發. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Mortality </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 長期.Complication </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Lost.follow.up </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 術後住院天數..day. </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Cystoscope.Followup.month </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 手術到死亡間隔時間..月. </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Last.CT.or.MRI.Date </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Last.OPD.follow.up.Date </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Earliest.recurrent.or.mets.Date </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Longest.follow.up.month.for.BDFS.DFS </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 診斷年紀 </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 性別參數 </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> 術前eGFR.MDRD.ml.min.1.73m2 </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Post.OP.1.month.eGFR </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> last.Cr年紀 </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> last.eGFR </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6928 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 無症狀 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 男 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 28.9 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 172.7 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 86.1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 HTN </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Gross hematuria </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 右 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 腎盂 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 ≥ 3cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 stage III </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0  nil </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 adjuvant </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2015/08/12 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Open incision </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 By incision wound (Without bag) </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes，沒有復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 無法判斷生死 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 5 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 85.1511170 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/09/22 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/10/06 </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 97.7989488 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 43.77002 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 71.351355 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> Inf </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 51.88227 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 73.209340 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6926 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 無症狀 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 男 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 25.2 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 158.0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 63.0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8 ESRD (HD), 13 Psychiartic </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Gross hematuria </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 左 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 腎盂 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 ≥1 &amp; &amp;#60; 2 cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 stage I </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8  ESRD/ CRI </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/08/30 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 全部 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 不知道 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 無法判斷生死 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> ESRD </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 5 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/09/21 </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0.7227332 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 73.78234 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 13.943400 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> Inf </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 73.80424 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 4.632458 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6925 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 有症狀,可步行對生活不影響 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 男 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 24.2 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 166.0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 66.8 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 HTN, 10 DM, 13 Psychiartic </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Gross hematuria, Flank pain </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 右 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 上輸尿管 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 &amp;#60;1cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6 stage IV </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8  ESRD/ CRI </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 positive </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 neo-adjuvant </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/06/23 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 7  Retroperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0   Not perform BCR </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8 術中膀胱灌藥-Epirubicin </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Grade II: </td>\n   <td style=\"text-align:left;font-size: 11px;\"> pRBC 2U </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Lung metastasis </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/03/13 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 NUx 後復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 5 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2024/03/12 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2024/05/01 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/03/13 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 10.2825230 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 74.34360 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 48.207110 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> Inf </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 75.06365 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 62.124999 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 14 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6909 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 無症狀 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 男 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 23.2 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 163.0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 61.7 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 10 DM </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Gross hematuria, Flank pain </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 右 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 下輸尿管 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 ≥ 3cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6 stage IV </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8  ESRD/ CRI </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 adjuvant </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2021/12/27 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 全部 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> iliac </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8 術中膀胱灌藥-Epirubicin </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Liver metastasis </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/02/15 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 NUx 後復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 無法判斷生死 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 7 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/04/15 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/04/25 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/02/15 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 3.9093298 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 66.09172 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 51.737379 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 52.57331 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 66.39014 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 52.952341 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 19 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6904 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 有症狀,可步行對生活不影響 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 女 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 19.6 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 147.0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 42.4 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 CAD </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Incidental finding </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 左 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 腎盂 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 ≥2 &amp; &amp;#60; 3 cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6 stage IV </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0  nil </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 adjuvant </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/06/28 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> para-aortic/caval </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8 術中膀胱灌藥-Epirubicin </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Transfusion  pRBC 2U </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 Bone metastasis, 2 Lung metastasis </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/10/16 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 NUx 後復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 20 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2024/03/22 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2024/04/23 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/10/16 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 9.8554534 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 77.14168 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 65.343304 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 65.34330 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 77.96304 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 44.886210 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 21 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6900 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 有症狀,可步行對生活不影響 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 男 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 23.7 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 172.0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 70.2 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 HTN, 10 DM, 16 malignancy (非UTUC/ bladder UC) </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Incidental finding </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 右 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 腎盂 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 ≥2 &amp; &amp;#60; 3 cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 stage I </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 13 previous bladder UC, 7  prior C/T or R/T </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Concurrent Bladder UC </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/06/21 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 全部 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8 術中膀胱灌藥-Epirubicin </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Grade I: </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 傷口痛 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes，沒有復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 9 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 16.5571616 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/11/08 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/11/16 </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 16.8528252 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 72.94193 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 76.973581 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> Inf </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 74.32455 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 92.312790 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 33 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6878 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 有症狀,可步行對生活不影響 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 女 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 19.4 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 156.5 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 47.6 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8 ESRD (HD), 2 CAD </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Incidental finding </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 UC with variants (Squamous cell, glandular, sarcomatous, micro papillary, neuroendocrine, lymphoepithelial) </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 右 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 腎盂 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 ≥2 &amp; &amp;#60; 3 cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 stage 0a </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 13 previous bladder UC, 8  ESRD/ CRI </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Previous  Hx of bladder UC </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/02/14 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 全部 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> pelvic </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Grade I: </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 傷口痛 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes，沒有復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 5 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/03/30 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/10/06 </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 19.6780552 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 74.56548 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 3.156436 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> Inf </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 74.56822 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 4.879998 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 35 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6876 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 無症狀 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 女 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 22.6 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 152.0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 52.3 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 CAD </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Gross hematuria </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 右 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 中輸尿管 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 ≥ 3cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 stage I </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8  ESRD/ CRI </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2022/03/14 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 全部 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> iliac </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Grade II: </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 腸阻塞 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes，沒有復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 18 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 13.0091984 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/04/14 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/08/04 </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 18.9553219 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 87.97262 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 52.572890 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> Inf </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 89.55236 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 58.090379 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 41 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6843 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 無症狀 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 女 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 29.1 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 153.4 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 68.4 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 13 Psychiartic </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Gross hematuria </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 左 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 腎盂 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 ≥ 3cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6 stage IV </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8  ESRD/ CRI </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 positive </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 salvage (curative intent) </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2019/02/14 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> para-aortic/caval </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 Grade II: </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 20190218 CT: hemoperitoemum and acute hematoma in the left paraaortic region and renal fossa and subcutaneous space of anterior abdominal wall (with Ceftriaxone)\n20190219 Echo: moderate pericardial effusion without echo tamponade sign (with seretide spray) </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 不知道 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 死因不明 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 9 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0.8869908 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 36.00526 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2019/02/18 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2019/05/02 </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 2.5295664 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 71.83573 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 42.437389 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 29.98600 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 72.00821 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 28.480796 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 42 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6839 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 無症狀 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 男 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 29.0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 177.9 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 91.7 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5 HTN, 10 DM </td>\n   <td style=\"text-align:left;font-size: 11px;\"> Gross hematuria, Flank pain </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 urothelial </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2 右 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 腎盂 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 &amp;#60;1cm </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 stage 0a </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 3 high grade </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1  smoking </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 free </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2018/10/15 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 6  Transperitoneal, 3  Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 5   Robot assisted </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4 commercial endo-bag </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 10 Yes, Epirubicin </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Grade I: </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 20181016 fever (with Cefazolin) </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1 Yes，沒有復發或轉移 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 no </td>\n   <td style=\"text-align:left;font-size: 11px;\"> No Complication </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0 No </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 8 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 55.8804205 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> NA </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/06/12 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2023/06/20 </td>\n   <td style=\"text-align:left;font-size: 11px;\">  </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 56.1432326 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 48.90075 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 86.438455 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> Inf </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 53.55784 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 64.080769 </td>\n  </tr>\n</tbody>\n</table></div>\n\n`````\n:::\n:::\n\n\n\n\n### 2 Summarrize the original data table\n\n<style>\n.code_out{\n  white-space: pre !important;\n  overflow-y: scroll !important;\n  height: 400px !important;\n}\n\n</style>\n\n\n::: {.cell}\n\n```{.r .cell-code}\nsummary(RobatLpsLess)\n```\n\n::: {.cell-output .cell-output-stdout}\n\n``` code_out\n      編號          Group           ECOG               性別          \n Min.   :   3   Min.   :1.000   Length:1967        Length:1967       \n 1st Qu.:2584   1st Qu.:2.000   Class :character   Class :character  \n Median :4325   Median :2.000   Mode  :character   Mode  :character  \n Mean   :4011   Mean   :1.773                                        \n 3rd Qu.:5038   3rd Qu.:2.000                                        \n Max.   :6928   Max.   :2.000                                        \n                                                                     \n      BMI          身高..公分.      體重..公斤.     Comorbidity.多選. \n Min.   :  0.20   Min.   : 135.0   Min.   : 29.70   Length:1967       \n 1st Qu.: 21.30   1st Qu.: 152.0   1st Qu.: 51.73   Class :character  \n Median : 23.70   Median : 158.0   Median : 60.00   Mode  :character  \n Mean   : 24.38   Mean   : 159.2   Mean   : 61.22                     \n 3rd Qu.: 26.60   3rd Qu.: 164.0   3rd Qu.: 68.00                     \n Max.   :240.20   Max.   :1552.0   Max.   :646.00                     \n NA's   :720      NA's   :718      NA's   :717                        \n 術前主述.複選.      Cell.Type            左右側          腫瘤位置.多選.    \n Length:1967        Length:1967        Length:1967        Length:1967       \n Class :character   Class :character   Class :character   Class :character  \n Mode  :character   Mode  :character   Mode  :character   Mode  :character  \n                                                                            \n                                                                            \n                                                                            \n                                                                            \n    多發性            腫瘤大小           病理分期         完整檢體腫瘤惡性度\n Length:1967        Length:1967        Length:1967        Length:1967       \n Class :character   Class :character   Class :character   Class :character  \n Mode  :character   Mode  :character   Mode  :character   Mode  :character  \n                                                                            \n                                                                            \n                                                                            \n                                                                            \n 危險因子..複選.    合併膀胱腫瘤         合併CIS         \n Length:1967        Length:1967        Length:1967       \n Class :character   Class :character   Class :character  \n Mode  :character   Mode  :character   Mode  :character  \n                                                         \n                                                         \n                                                         \n                                                         \n Lymphovascular.invasion surgical.margin      術前水腎        \n Length:1967             Length:1967        Length:1967       \n Class :character        Class :character   Class :character  \n Mode  :character        Mode  :character   Mode  :character  \n                                                              \n                                                              \n                                                              \n                                                              \n Tumor.Necrosis     有無針對UTUC化療   針對UTUC化療型態    NxUx.date        \n Length:1967        Length:1967        Length:1967        Length:1967       \n Class :character   Class :character   Class :character   Class :character  \n Mode  :character   Mode  :character   Mode  :character   Mode  :character  \n                                                                            \n                                                                            \n                                                                            \n                                                                            \n NxUx.Access.method..複選. Other.NxUx.access.method Bladder.cuff.resection\n Length:1967               Length:1967              Length:1967           \n Class :character          Class :character         Class :character      \n Mode  :character          Mode  :character         Mode  :character      \n                                                                          \n                                                                          \n                                                                          \n                                                                          \n other.bladder.cuff.method Lymphadenectomy.位置.複選.\n Length:1967               Length:1967               \n Class :character          Class :character          \n Mode  :character          Mode  :character          \n                                                     \n                                                     \n                                                     \n                                                     \n simultaneously.ipsilateral.adrenalectomy\n Length:1967                             \n Class :character                        \n Mode  :character                        \n                                         \n                                         \n                                         \n                                         \n Specimen.retrieval..註.若直接從傷口取出則選1.or.2.若有使用bag選擇輸入4.5.\n Length:1967                                                              \n Class :character                                                         \n Mode  :character                                                         \n                                                                          \n                                                                          \n                                                                          \n                                                                          \n Post.operation.intravesical.C.T.instillation\n Length:1967                                 \n Class :character                            \n Mode  :character                            \n                                             \n                                             \n                                             \n                                             \n Clavien.Dindo.classification.複選.\n Length:1967                       \n Class :character                  \n Mode  :character                  \n                                   \n                                   \n                                   \n                                   \n complication.list..請填寫手術併發症中英文均可. 淋巴轉移及位置..複選.\n Length:1967                                    Length:1967          \n Class :character                               Class :character     \n Mode  :character                               Mode  :character     \n                                                                     \n                                                                     \n                                                                     \n                                                                     \n Date.of.LN.mets    遠端轉移.複選.     Date.of.distant.mets\n Length:1967        Length:1967        Length:1967         \n Class :character   Class :character   Class :character    \n Mode  :character   Mode  :character   Mode  :character    \n                                                           \n                                                           \n                                                           \n                                                           \n Disease.free.註.不含膀胱內復發.  Mortality         長期.Complication \n Length:1967                     Length:1967        Length:1967       \n Class :character                Class :character   Class :character  \n Mode  :character                Mode  :character   Mode  :character  \n                                                                      \n                                                                      \n                                                                      \n                                                                      \n Lost.follow.up     術後住院天數..day. Cystoscope.Followup.month\n Length:1967        Min.   : 2.000     Min.   : -0.7227         \n Class :character   1st Qu.: 6.000     1st Qu.: 11.1695         \n Mode  :character   Median : 7.000     Median : 24.2116         \n                    Mean   : 8.187     Mean   : 31.3262         \n                    3rd Qu.: 9.000     3rd Qu.: 45.0723         \n                    Max.   :91.000     Max.   :211.8265         \n                    NA's   :332        NA's   :504              \n 手術到死亡間隔時間..月.     備註           Last.CT.or.MRI.Date\n Min.   :     -51        Length:1967        Length:1967        \n 1st Qu.:      12        Class :character   Class :character   \n Median :      27        Mode  :character   Mode  :character   \n Mean   :   32291                                              \n 3rd Qu.:      48                                              \n Max.   :16708534                                              \n NA's   :1449                                                  \n Last.OPD.follow.up.Date Earliest.recurrent.or.mets.Date\n Length:1967             Length:1967                    \n Class :character        Class :character               \n Mode  :character        Mode  :character               \n                                                        \n                                                        \n                                                        \n                                                        \n Longest.follow.up.month.for.BDFS.DFS    診斷年紀         性別參數     \n Min.   :  0.03285                    Min.   : 23.56   Min.   :0.0000  \n 1st Qu.: 14.68463                    1st Qu.: 62.14   1st Qu.:0.0000  \n Median : 30.78187                    Median : 69.57   Median :1.0000  \n Mean   : 37.73407                    Mean   : 68.80   Mean   :0.5872  \n 3rd Qu.: 53.68758                    3rd Qu.: 76.34   3rd Qu.:1.0000  \n Max.   :215.11170                    Max.   :100.96   Max.   :1.0000  \n NA's   :39                           NA's   :6                        \n 術前eGFR.MDRD.ml.min.1.73m2 Post.OP.1.month.eGFR  last.Cr年紀    \n Min.   : 1.804              Min.   : 0.5861      Min.   : 23.83  \n 1st Qu.:31.520              1st Qu.:49.4479      1st Qu.: 65.77  \n Median :50.988              Median :    Inf      Median : 72.47  \n Mean   :   Inf              Mean   :    Inf      Mean   : 71.93  \n 3rd Qu.:69.887              3rd Qu.:    Inf      3rd Qu.: 78.96  \n Max.   :   Inf              Max.   :    Inf      Max.   :102.22  \n NA's   :2                   NA's   :4            NA's   :431     \n   last.eGFR    \n Min.   : 0.00  \n 1st Qu.:21.53  \n Median :48.73  \n Mean   :  Inf  \n 3rd Qu.:82.13  \n Max.   :  Inf  \n NA's   :3      \n```\n\n\n:::\n:::\n\n\n### 3 Check the missing value\n\n\n::: {.cell}\n::: {.cell-output-display}\n`````{=html}\n<div style=\"border: 1px solid #ddd; padding: 0px; overflow-y: scroll; height:400px; overflow-x: scroll; width:100%; \"><table class=\"table table-striped table-hover table-condensed lightable-paper\" style='color: black; margin-left: auto; margin-right: auto; color: black; font-family: \"Arial Narrow\", arial, helvetica, sans-serif; margin-left: auto; margin-right: auto;'>\n <thead>\n  <tr>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> Variables </th>\n   <th style=\"text-align:right;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> N </th>\n   <th style=\"text-align:left;position: sticky; top:0; background-color: #FFFFFF;font-size: 14px;\"> P </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 編號 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> ECOG </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 201 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 10% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 性別 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 身高..公分. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 263 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 13% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 體重..公斤. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 717 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 36% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Comorbidity.多選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 81 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 術前主述.複選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 31 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Cell.Type </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 左右側 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 腫瘤位置.多選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 多發性 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 腫瘤大小 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 病理分期 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 13 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 完整檢體腫瘤惡性度 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 15 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 危險因子..複選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 合併膀胱腫瘤 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 合併CIS </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 3 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Lymphovascular.invasion </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 29 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> surgical.margin </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 術前水腎 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 2 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Tumor.Necrosis </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 167 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 8% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 有無針對UTUC化療 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 針對UTUC化療型態 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1113 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 57% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> NxUx.date </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> NxUx.Access.method..複選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Other.NxUx.access.method </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 786 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 40% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Bladder.cuff.resection </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 20 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> other.bladder.cuff.method </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 747 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 38% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Lymphadenectomy.位置.複選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 716 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 36% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> simultaneously.ipsilateral.adrenalectomy </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 172 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 9% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Specimen.retrieval..註.若直接從傷口取出則選1.or.2.若有使用bag選擇輸入4.5. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 173 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 9% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Post.operation.intravesical.C.T.instillation </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 13 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Clavien.Dindo.classification.複選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 70 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> complication.list..請填寫手術併發症中英文均可. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 533 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 27% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 淋巴轉移及位置..複選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 87 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Date.of.LN.mets </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 遠端轉移.複選. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 82 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 4% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Date.of.distant.mets </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Disease.free.註.不含膀胱內復發. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Mortality </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 長期.Complication </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 18 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 1% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Lost.follow.up </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 術後住院天數..day. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 332 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 17% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Cystoscope.Followup.month </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 504 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 26% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 手術到死亡間隔時間..月. </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 1449 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 74% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 備註 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Last.CT.or.MRI.Date </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Last.OPD.follow.up.Date </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Earliest.recurrent.or.mets.Date </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Longest.follow.up.month.for.BDFS.DFS </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 39 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 2% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 診斷年紀 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 6 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 性別參數 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 0 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> 術前eGFR.MDRD.ml.min.1.73m2 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 2 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> Post.OP.1.month.eGFR </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 4 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> last.Cr年紀 </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 431 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 22% </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;font-size: 11px;\"> last.eGFR </td>\n   <td style=\"text-align:right;font-size: 11px;\"> 3 </td>\n   <td style=\"text-align:left;font-size: 11px;\"> 0% </td>\n  </tr>\n</tbody>\n</table></div>\n\n`````\n:::\n:::\n\n\n",
    "supporting": [
      "Example1_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<script src=\"../site_libs/kePrint-0.0.1/kePrint.js\"></script>\n<link href=\"../site_libs/lightable-0.0.1/lightable.css\" rel=\"stylesheet\" />\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}